As of today (2024-05-14), Viela Bio's share price is $53.01. Viela Bio's Tangible Book per Share of Dec. 2020 for the quarter that ended in Dec. 2020 was $6.51. Hence, Viela Bio's Price to Tangible Book Ratio of today is 8.15.
The historical rank and industry rank for Viela Bio's Price-to-Tangible-Book or its related term are showing as below:
VIE'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.88 Med: 4.71 Max: 8.14
Current: 8.14
During the past 3 years, Viela Bio's highest Price to Tangible Book Ratio was 8.14. The lowest was 3.88. And the median was 4.71.
VIE's Price-to-Tangible-Book is not ranked
in the Biotechnology industry.
Industry Median: 2.71
vs VIE: 8.14
A closely related ratio is called PB Ratio. As of today, Viela Bio's share price is $53.01. Viela Bio's Book Value per Sharefor the quarter that ended in Dec. 2020 was $6.85. Hence, Viela Bio's P/B Ratio of today is 7.74.
Viela Bio Price-to-Tangible-Book Historical Data
The historical data trend for Viela Bio's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Viela Bio's Price-to-Tangible-Book
For the Biotechnology subindustry, Viela Bio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viela Bio's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Viela Bio's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Viela Bio's Price-to-Tangible-Book falls into.
Viela Bio Price-to-Tangible-Book Calculation
Viela Bio's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Viela Bio Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Viela Bio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VIE has been successfully added to your 